News for Addex Therapeutics Ltd (0QNV.L)

Addex Therapeutics (ADXN) has revealed promising findings regarding the anti-tussive effectiveness of its innovative gamma-aminobutyric acid sub-type B receptor

Addex Therapeutics, known by its ticker ADXN, has entered into a strategic partnership with Sinntaxis AB. This collaboration focuses on an exclusive license con

Series A Financing: USD65 million raised for Neurosterix, led by Perceptive Advisors.Cash Received: CHF5 million in cash from the Neurosterix transaction.Equit

Addex Therapeutics Ltd (NASDAQ:ADXN) Q4 2024 Earnings Conference Call April 25, 2025 10:00 AM ETCompany ParticipantsTim Dyer - Co-Founder, Board Director...

Addex Therapeutics (ADXN) disclosed that it has reacquired all development and commercialization rights to ADX71149 after the termination of its collaboration w

Revenue: CHF0.1 million in Q3 2024, compared to CHF0.3 million in Q3 2023.R&D Expenses: CHF0.2 million in Q3 2024, decreased by CHF0.3 million from Q3 2023.G&A

Addex Therapeutics Ltd (NASDAQ:ADXN) Q3 2024 Earnings Conference Call November 22, 2024 10:00 AM ETCompany ParticipantsTim Dyer - Co-Founder, Board Director...

Texas-based Genprex, Inc. (GNPX), a clinical-stage gene therapy company is up over 103 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of iRhythm Technologies, Inc. IRTC rose sharply in today's pre-market trading after the company announced that it was granted FDA clearance for its 510(k...

Series A Financing: USD 63 million led by Perceptive Advisors.Equity Interest in Neurosterix: CHF 5 million and a 20% equity interest.Milestone Payments: Up to

Sep 30, 2024 / 02:00PM GMTTim Dyer - Addex Therapeutics Ltd - Chief Executive Officer, Co-Founder, Member of the Executive Management, Director Hello, everyone.

Earnings call: Addex Therapeutics reports half-year financials and R&D updates

Addex Therapeutics Ltd (NASDAQ:ADXN) Q2 2024 Earnings Conference Call September 30, 2024 10:00 AM ETCompany ParticipantsTim Dyer - Co-Founder, Board...

California-based Bolt Projects Holdings, Inc. (BSLK) is up over 103 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.2% on Tuesday. The Dow traded up 0.01% to 41,242.33 while the NASDAQ rose...

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling around 0.2% on Tuesday. The Dow traded down 0.16% to 41,175.13 while t...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.16...

Ireland-based Trinity Biotech plc (TRIB) is up over 103 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.